| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,215 |
17,883 |
$768K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,658 |
5,181 |
$176K |
| 95886 |
|
2,068 |
1,790 |
$170K |
| 64483 |
|
1,442 |
1,133 |
$145K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,067 |
4,238 |
$123K |
| 95911 |
|
505 |
476 |
$66K |
| 99152 |
|
3,505 |
2,624 |
$57K |
| 64493 |
|
711 |
512 |
$56K |
| 95910 |
|
451 |
399 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
511 |
456 |
$34K |
| 64494 |
|
651 |
471 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,229 |
2,723 |
$19K |
| 20553 |
|
414 |
359 |
$9K |
| 64495 |
|
290 |
195 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,724 |
5,082 |
$6K |
| 95909 |
|
75 |
59 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,267 |
1,049 |
$4K |
| J3490 |
Unclassified drugs |
2,211 |
1,672 |
$3K |
| 99000 |
|
4,210 |
3,604 |
$3K |
| 95912 |
|
29 |
27 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,222 |
2,684 |
$3K |
| 99442 |
|
84 |
73 |
$1K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
420 |
351 |
$1K |
| 64479 |
|
16 |
12 |
$1K |
| 20552 |
|
36 |
28 |
$489.99 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,526 |
2,645 |
$310.37 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
229 |
209 |
$127.24 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
865 |
732 |
$50.03 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,156 |
947 |
$1.42 |